MOH Essentials

Discover a dynamic new resource for compression therapy. MOH Essentials provides basic information, study summaries and expert lectures that are continually updated to keep you abreast of the latest advances in compression therapy.

Compression therapy applies pressure to the body to improve circulation and reduce symptoms of venous and lymphatic disorders. It includes various devices such as compression bandages, stockings, adjustable systems, and pneumatic compression. These treatments help reduce vein diameter, increase blood flow, reduce swelling and improve healing. Compression therapy is effective in treating both acute and chronic conditions, preventing venous complications and aiding recovery.

Compression therapy is a key treatment for chronic venous disease and is supported by recent guidelines. It uses various devices such as compression stockings, bandages, adjustable systems and pneumatic devices. Compression is recommended to relieve venous symptoms, reduce swelling, improve skin conditions and improve the patient's quality of life. Stockings with a pressure range of 15-40 mm Hg, depending on severity, are recommended to manage symptoms, prevent complications and treat problems such as varicose veins, eczema and lipodermatosclerosis.

Compression therapy plays a critical role in the treatment and prevention of venous leg ulcers, as supported by international guidelines. It promotes healing, reduces recurrence and relieves pain. Studies show that consistent use of compression stockings significantly reduces ulcer recurrence rates. In addition, compression is recommended after venous interventions such as surgery and sclerotherapy to reduce post-operative side effects such as pain and swelling, with prolonged use recommended for those with persistent venous insufficiency.

Compression therapy is essential immediately after deep vein thrombosis (DVT) to reduce pain and swelling and promote mobilization. Used in conjunction with anticoagulation, it helps prevent clot progression. Compression also reduces the risk of post-thrombotic syndrome (PTS) and alleviates symptoms such as pain and skin changes. Individualized treatment ranges from 6 to 12 months based on symptom improvement, with ongoing use recommended for persistent PTS symptoms. Compression is also recommended for superficial venous thrombosis.

Compression therapy is generally safe, but may cause side effects such as skin irritation, discomfort, or rare complications such as infection, nerve damage, or arterial problems. Contraindications include severe peripheral arterial disease with low ankle or toe pressures and advanced heart failure (NIHA stage 4). Patients with heart failure or diabetes should be closely monitored. Compression should be avoided in cases of severe diabetic neuropathy or arterial bypass compression. Proper use and assessment of arterial circulation are essential before initiating treatment.